Company Imolapharm Srl with Fiscal Code 17260536
recorded a turnover of 2024 of
434.346,
with a net profit of
26.701
and having an average number of employees of
4.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Imolapharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
159.188
139.285
152.333
180.978
204.518
260.937
304.682
398.904
397.254
434.346
Total Income - EUR
159.205
139.290
152.335
180.980
204.525
260.941
304.688
398.911
397.266
439.897
Total Expenses - EUR
152.614
140.750
153.376
177.327
192.264
238.105
276.609
363.349
355.956
407.895
Gross Profit/Loss - EUR
6.591
-1.460
-1.041
3.652
12.261
22.836
28.079
35.561
41.310
32.001
Net Profit/Loss - EUR
5.072
-1.673
-2.459
1.842
10.216
20.453
25.192
32.208
38.095
26.701
Employees
3
3
3
3
3
3
4
5
4
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 10.0%, from 397.254 euro in the year 2023, to 434.346 euro in 2024.
The Net Profit decreased by -11.181 euro, from 38.095 euro in 2023, to 26.701 in the last year.
Check the financial reports for the company - Imolapharm Srl
Financial Rating - IMOLAPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Imolapharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Imolapharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Imolapharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
146.899 euro in 2024 which includes Inventories of
81.505 euro, Receivables of
50.527 euro and cash availability of
14.867 euro.
The company's Equity was valued at
26.750 euro, while total Liabilities amounted to
161.529 euro.
Equity decreased by -15.798 euro, from 42.787 euro in 2023, to 26.750 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Imolapharm Srl